Client News

AiCuris´ innovation accelerator AiCubator calls for innovative proposals to propel anti-infective drug development in the third round

ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022

Destiny Pharma: Notice of R&D Update Meeting

Spexis announces positive renal impairment clinical trial results with balixafortide

CEVEC: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing

Atriva Therapeutics announces Topline Results from the Proof of Concept (POC) / Phase 2a RESPIRE study (zapnometinib) in patients hospitalized with COVID-19

ABIVAX PRESENTS FIRST-HALF 2022 FINANCIAL RESULTS AND OPERATIONS UPDATE

Newron provides H1 2022 results and updates on R&D and business activities

Marinomed to attend several upcoming investor and industry conferences

HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery